US Food and Drug Administration headquarters sign

REGULATORY

12 Feb 2026

FDA’s Quality Revamp Could Reshape Drug Filings

FDA’s draft ICH M4Q update pushes drugmakers to prepare for globally aligned CMC submissions

Laboratory vial marked peptide held by researcher in blue gloves

INNOVATION

11 Feb 2026

Why Peptide Synthesis Is Entering the Fast Lane

Automated synthesis speeds peptide drug development, cuts solvent use, and reshapes competition across a fast-growing market

Takeda logo mounted on exterior wall of corporate building

PARTNERSHIPS

10 Feb 2026

AI Deals Reshape Drug Discovery Strategies

Takeda’s pact with Iambic reflects a wider shift to AI-led research to cut risk, shorten timelines and sharpen investment

Syringe and assorted capsules and tablets placed on a flat surface

INVESTMENT

9 Feb 2026

Capital Rush Signals New Phase in Obesity Drug Investing

Recent large early-stage raises, led by Alveus at $159.8M, highlight rising competition with Novo Nordisk and Eli Lilly

Scientist examining samples under a microscope in a pharmaceutical lab

INNOVATION

6 Feb 2026

AI Alliances Are Reshaping Peptide Manufacturing in America

Grace and Molecule.one apply AI and automation to ease peptide bottlenecks, signaling a shift toward faster, more resilient US drug manufa...

Pharmaceutical manufacturing facility with large stainless steel production tanks

MARKET TRENDS

5 Feb 2026

Why Peptide Drugmakers Are Betting Big on Factories

Soaring demand is forcing peptide drugmakers to rethink strategy, shifting focus from discovery toward manufacturing scale, reliability, a...

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.